- Home
- PHM vs DGX Comparison
PHM vs DGX Comparison
Compare PHM & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHM
- DGX
- Stock Information
- Founded
- PHM 1950
- DGX 1967
- Country
- PHM United States
- DGX United States
- Employees
- PHM N/A
- DGX N/A
- Industry
- PHM Homebuilding
- DGX Medical Specialities
- Sector
- PHM Consumer Discretionary
- DGX Health Care
- Exchange
- PHM Nasdaq
- DGX Nasdaq
- Market Cap
- PHM 21.0B
- DGX 19.8B
- IPO Year
- PHM N/A
- DGX 1996
- Fundamental
- Price
- PHM $114.76
- DGX $168.03
- Analyst Decision
- PHM Buy
- DGX Buy
- Analyst Count
- PHM 15
- DGX 14
- Target Price
- PHM $132.57
- DGX $185.07
- AVG Volume (30 Days)
- PHM 2.2M
- DGX 879.6K
- Earning Date
- PHM 07-22-2025
- DGX 07-22-2025
- Dividend Yield
- PHM 0.77%
- DGX 1.90%
- EPS Growth
- PHM 13.61
- DGX 6.41
- EPS
- PHM 14.20
- DGX 7.91
- Revenue
- PHM $17,890,440,000.00
- DGX $10,158,000,000.00
- Revenue This Year
- PHM N/A
- DGX $10.38
- Revenue Next Year
- PHM $2.46
- DGX $4.03
- P/E Ratio
- PHM $8.05
- DGX $21.29
- Revenue Growth
- PHM 8.86
- DGX 9.38
- 52 Week Low
- PHM $88.07
- DGX $137.71
- 52 Week High
- PHM $149.47
- DGX $182.38
- Technical
- Relative Strength Index (RSI)
- PHM 67.64
- DGX 31.61
- Support Level
- PHM $107.07
- DGX $171.29
- Resistance Level
- PHM $116.42
- DGX $174.47
- Average True Range (ATR)
- PHM 3.28
- DGX 2.88
- MACD
- PHM 0.93
- DGX -1.22
- Stochastic Oscillator
- PHM 88.36
- DGX 6.15
About PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.